A. Rismani

Most-cited papers

1. Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction

   A. Latifoltojar, M. Hall-Craggs, A. Bainbridge, N. Rabin +11 more

   2017European Radiology80 citations Open access

   Semantic Scholar

   Save

2. Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia

   N. Cross, Yvette Hoade, W. Tapper, Gonzalo Carreño-Tarragona +32 more

   2018Leukemia74 citations Open access

   Semantic Scholar

   Save

3. Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response

   A. Latifoltojar, M. Hall-Craggs, N. Rabin, R. Popat +7 more

   2016British Journal of Haematology65 citations Open access

   Semantic Scholar

   Save

4. Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design

   D. Koutoukidis, Joanne Land, A. Hackshaw, M. Heinrich +13 more

   2020British Journal of Cancer60 citations Open access

   Semantic Scholar

   Save

5. Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival

   Melody Chin, J. Sive, C. Allen, C. Roddie +11 more

   2017Blood Cancer Journal54 citations Open access

   Semantic Scholar

   Save

6. Real‐world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi‐centre UK experience

   N. Maciocia, A. Melville, S. Cheesman, F. Sharpley +12 more

   2017British Journal of Haematology29 citations Open access

   Semantic Scholar

   Save

7. Clinical and clonal characteristics of monoclonal immunoglobulin M‐associated type I cryoglobulinaemia

   J. Khwaja, Josephine M. I. Vos, Tessa E Pluimers, Nicole Japzon +8 more

   2023British Journal of Haematology22 citations Open access

   Semantic Scholar

   Save

8. Bortezomib‐based therapy is effective and well tolerated in frontline and multiply pre‐treated Waldenström macroglobulinaemia including BTKi failures: A real‐world analysis

   J. Khwaja, E. Uppal, R. Baker, Kajal Trivedi +5 more

   2022eJHaem11 citations Open access

   Semantic Scholar

   Save

9. Vial Sharing of Bortezomib Is Logistically Feasible and Significantly Reduces Drug Wastage and the Cost of Myeloma Treatment

   S. Cheesman, A. Shields, R. Shah, N. Thakrar +10 more

   20167 citations Open access

   Semantic Scholar

   Save

10. Patient reported outcome measures in Waldenström macroglobulinaemia: A real‐world data analysis from the WMUK Rory Morrison Registry

    J. Khwaja, E. Uppal, Sotirios Bristogiannis, H. McCarthy +7 more

    2022eJHaem6 citations Open access

    Semantic Scholar

    Save

11. Cold agglutinin disease and cryoglobulinaemia: A frequent coexistence with clinical impact

    J. Khwaja, Nicole Japzon, Maria Gabriel, Kavin Raju +5 more

    2023British Journal of Haematology5 citations

    Semantic Scholar

    Save

12. Type 1 Cryoglobulinaemia Associated with Waldenström Macroglobulinemia, IgM MGUS or Non-Hodgkin Lymphoma

    J. Khwaja, S. Salter, Aisha S Patel, R. Baker +6 more

    2022Blood4 citations Open access

    Semantic Scholar

    Save

13. Neuropathy with IgM Gammopathy: Incidence, Characteristics and Management, a Rory Morrison W.M.U.K Registry Analysis

    O. Tomkins, J. Lindsay, S. Keddie, A. Carr +8 more

    20204 citations Open access

    Semantic Scholar

    Save

14. PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia

    Jaimal Kothari, T. Eyre, A. Rismani, Kushani Ediriwickrema +14 more

    2024British Journal of Haematology3 citations Open access

    Semantic Scholar

    Save

15. IBCL-099 Intensive Chemotherapy and Autologous Stem Cell (ASCT) Consolidation for Bing Neel Syndrome

    J. Khwaja, Nicole Japzon, A. Rismani, A. Carr +3 more

    2023Clinical Lymphoma, Myeloma & Leukemia3 citations Open access

    Semantic Scholar

    Save

16. Real World Experience on the Use of Ibrutinib Monotherapy in Waldenström Macroglobulinemia

    O. Ogunbiyi, Suzanne O. Arulogun, Aisha S Patel, A. Rismani +2 more

    2021Blood3 citations Open access

    Semantic Scholar

    Save

17. Physical and Psychological Factors Influencing Fatigue and Quality of Life in Multiple Myeloma Survivors: Preliminary Results from the Mascot Lifestyle Study

    M. Heinrich, Joanne Land, O. McCourt, S. Philpott +11 more

    20163 citations

    Semantic Scholar

    Save

18. Outcome of Pomalidomide Therapy in Relapsed /Refractory Myeloma: A Uk Multi-Centre Experience

    N. Maciocia, F. Sharpley, E. Belsham, H. Renshaw +11 more

    20153 citations

    Semantic Scholar

    Save

19. Pembrowm: Results of a Multi-Centre Phase II Trial Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia

    Jaimal Kothari, T. Eyre, A. Rismani, H. McCarthy +12 more

    2022Blood2 citations

    Semantic Scholar

    Save

20. Autologous Haematopoietic Stem Cell Transplantation in Waldenström Macroglobulinemia: A Single-Centre 18-Year Experience

    Suzanne O. Arulogun, C. Kyriakou, J. Horder, F. Newrick +5 more

    2021Blood2 citations Open access

    Semantic Scholar

    Save

21. High-Dose Methotrexate Based Therapy for the Treatment of Bing Neel Syndrome

    Suzanne O. Arulogun, M. Lunn, C. Hoskote, A. Carr +4 more

    20202 citations Open access

    Semantic Scholar

    Save

22. A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1

    S. Chavda, P. Maciocia, P. Mesiri, N. Counsell +12 more

    2018British Journal of Haematology2 citations Open access

    Semantic Scholar

    Save

23. Fatigue, Quality of Life, and Physical Fitness Following an Exercise Intervention in Survivors of Multiple Myeloma: A Randomised Controlled Trial Using a Zelen Design

    Joanne Sowter, D. Koutoukidis, M. Heinrich, O. McCourt +12 more

    2018Blood2 citations

    Semantic Scholar

    Save

24. Real world experience of bortezomib re‐treatment for patients with multiple myeloma at first relapse

    Y. Reyal, R. Popat, S. Cheesman, A. Rismani +3 more

    2017British Journal of Haematology2 citations Open access

    Semantic Scholar

    Save

25. A UK-wide analysis of the use of reversal agents in 198 patients on direct oral anticoagulants prior to urgent procedures

    Molly Michala Jasmine David J. Bryar Andrew Gillian Rita Murphy Pettitt Makker Sutton Kaddir Doyle Lowe Per, M. Murphy, M. Pettitt, Jasmine Makker +399 more

    2026Research and Practice in Thrombosis and Haemostasis1 citations Open access

    Semantic Scholar

    Save

26. P1150: REAL WORLD DATA ON BORTEZOMIB-BASED THERAPY IN WALDENSTRÖM’S MACROGLOBULINAEMIA: EFFECTIVE EVEN IN MULTIPLY TREATED PATIENTS INCLUDING PRIOR BTK-INHIBITORS

    E. Uppal, J. Khwaja, A. Rismani, C. Kyriakou +1 more

    2022HemaSphere1 citations Open access

    Semantic Scholar

    Save

27. P1112: TREATING BING-NEEL SYNDROME USING A TAILORED APPROACH: EXPERIENCE OF A SPECIALIST NEUROHAEMATOLOGY CLINIC

    J. Khwaja, D. Smyth, A. Rismani, C. Hoskote +3 more

    2022HemaSphere1 citations Open access

    Semantic Scholar

    Save

28. IgM Paraprotein-Associated Type 1 Cryoglobulinaemia: Clinical Characteristics and Outcomes

    J. Khwaja, Aisha S Patel, Suzanne O. Arulogun, A. Rismani +4 more

    2021Blood1 citations Open access

    Semantic Scholar

    Save

29. Real-World Use of Pomalidomide and Dexamethasone in Double Refractory Multiple Myeloma: A Multicentre UK Experience

    N. Maciocia, A. Melville, P. Maciocia, S. Cheesman +11 more

    20161 citations

    Semantic Scholar

    Save

30. Prevalence of TP53 Mutations in Del(17p) Myeloma: Spectrum of Mutations and Effect on Survival

    Melody Chin, J. Sive, C. Allen, C. Roddie +8 more

    20161 citations

    Semantic Scholar

    Save

31. Whole Body (WB) MRI in Newly Diagnosed Multiple Myeloma (MM): Fat Fraction Changes at 8 Weeks Predict Response to Induction with Bortezomib Regimens

    A. Latifoltojar, K. Yong, M. Hall-Craggs, N. Rabin +7 more

    20151 citations

    Semantic Scholar

    Save

32. Ethnic Diversity in Presentation of Waldenström Macroglobulinaemia and IgM Mgcs in the United Kingdom- a Real-World Data Analysis

    J. Khwaja, Nicole Japzon, Maria Gabriel, Charles Lilley +3 more

    2023Blood0 citations Open access

    Semantic Scholar

    Save

33. PB2549: CO-EXISTENT COLD AGGLUTININ DISEASE AND CRYOGLOBULINAEMIA

    Nicole Japzon, J. Khwaja, M. Gabriel, Kavin Raju +4 more

    2023HemaSphere0 citations Open access

    Semantic Scholar

    Save

34. TREATMENT OF BING NEEL SYNDROME: USING A SLEDGEHAMMER TO CRACK A NUT?

    J. Bomsztyk, P. Jareonsettasin, A. Rismani, S. Keddie +7 more

    2019Hematological Oncology0 citations

    Semantic Scholar

    Save

35. BING NEEL SYNDROME: FIRST SUSPECT, THEN PROVE ‐ A ROLE FOR CSF IgM ANALYSIS?

    J. Bomsztyk, P. Jareonsettasin, A. Carroll, S. Keddie +7 more

    2019Hematological Oncology0 citations

    Semantic Scholar

    Save

36. An Analysis from the WM UK Rory Morrison Registry - How Does Waldenström's Macroglobulinemia Affect Younger Patients?

    O. Tomkins, J. Bomsztyk, H. McCarthy, Jaimal Kothari +5 more

    2019Blood0 citations Open access

    Semantic Scholar

    Save

37. An Analysis from the WM UK Rory Morrison Registry: Waldenström's Macroglobulinaemia Patient Demographics, Disease Characteristics and Evolving Treatment Choices

    O. Tomkins, J. Bomsztyk, H. McCarthy, Jaimal Kothari +5 more

    2019Blood0 citations Open access

    Semantic Scholar

    Save

38. Castleman’s disease presenting as a spermatic cord lesion: case report and review of literature

    S. Renshaw, D. Arul, I. Proctor, Nick J. Owen +2 more

    20170 citations

    Semantic Scholar

    Save

39. Duration of Therapy Is Independently Associated with Improved Progression Free and Overall Survival Following First Line Therapy for Non-Transplant Eligible Patients with Multiple Myeloma: Retrospective Analysis from a Single Centre

    D. De-Silva, Adam S Bloomfield, N. Counsell, S. Cheesman +9 more

    20160 citations

    Semantic Scholar

    Save

40. Factors Influencing Outcomes of Relapse from Front-Line Autologous Stem Cell Transplant (ASCT) over a 14 Year Period: A Single Centre Experience

    S. Chavda, P. Maciocia, P. Mesiri, N. Counsell +12 more

    20160 citations

    Semantic Scholar

    Save

41. Use of an 'adapted Zelen' design in a randomised controlled trial of a physiotherapist-led exercise intervention in patients with myeloma.

    O. McCourt, M. Heinrich, A. Fisher, B. Paton +5 more

    20160 citations Open access

    Semantic Scholar

    Save

42. FATIGUE, QUALITY OF LIFE AND PHYSICAL FITNESS IN PATIENTS WITH MYELOMA

    O. McCourt, M. Heinrich, A. Fisher, B. Paton +5 more

    20160 citations

    Semantic Scholar

    Save

43. Use of serum free light chain assay in patients with plasma cell disorders - a re-audit

    Fnk Kwong, R. Popat, A. Rismani

    20140 citations

    Semantic Scholar

    Save